| 综述 |
|
|
|
|
| 端粒保护蛋白1(POT1)的研究进展 |
| 程凌利, 朱大柱, 黄迪南, 侯敢 |
| 广东医学院生物化学与分子生物学教研室 湛江 524023 |
|
| Advances of The Protection of Telomeres 1 |
| CHENG Ling-li, ZHU Da-zhu, HUANG Di-nan, HOU Gan |
| Institute of Biochemistry and Molecular Biology, Guangdong Medical College, Zhanjiang 524023, China |
引用本文:
程凌利, 朱大柱, 黄迪南, 侯敢. 端粒保护蛋白1(POT1)的研究进展[J]. 中国生物工程杂志, 2012, 32(07): 120-126.
CHENG Ling-li, ZHU Da-zhu, HUANG Di-nan, HOU Gan. Advances of The Protection of Telomeres 1. China Biotechnology, 2012, 32(07): 120-126.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I07/120
|
[1] Choi K H, Farrell A S, Lakamp A S, et al. Characterization of the DNA binding specificity of Shelterin complexes. Nucleic Acids Res, 2011, 39(21): 9206-9223.
[2] Altschuler S E, Dickey T H, Wuttke D S. Schizosaccharomyces pombe protection of telomeres 1 utilizes alternate binding modes to accommodate different telomeric sequences. Biochemistry, 2011, 50(35): 7503-7513.
[3] Croy J E, Altschuler S E, Grimm N E, et al. Nonadditivity in the recognition of single-stranded DNA by the schizosaccharomyces pombe protection of telomeres 1 DNA-binding domain, Pot1-DBD Biochemistry. 2009,48(29): 6864-6875.
[4] Nandakumar J, Cech T R. DNA-induced dimerization of the single-stranded DNA binding telomeric protein Pot1 from Schizosaccharomyces pombe. Nucleic Acids Res, 2012, 40(1): 235-244.
[5] Nandakumar J, Podell E R, Cech T R. How telomeric protein POT1 avoids RNA to achieve specificity for single-stranded DNA. Proc Natl Acad Sci USA, 2010, 107(2): 651-656.
[6] Kibe T, Osawa G A, Keegan C E, et al. Telomere protection by TPP1 is mediated by POT1a and POT1b. Mol Cell Biol, 2010, 30(4): 1059-1066.
[7] Hockemeyer D, Palm W, Else T, et al. Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat Struct Mol Biol, 2007, 14(8): 754-761.
[8] Xin H, Liu D, Wan M, et al. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature, 2007, 445(7127): 559-562.
[9] Liu D, Safari A, O’Connor M S, et al. PTOP interacts with POT1 and regulates its localization to telomeres. Nat Cell Biol, 2004, 6(7):673-680.
[10] Takai K K, Kibe T, Donigian J R, et al. Telomere protection by TPP1/POT1 requires tethering to TIN2. Mol Cell, 2011, 44(4): 647-659.
[11] Taylor D J, Podell E R, Taatjes D J, et al. Multiple POT1-TPP1 proteins coat and compact long telomeric single-stranded DNA. J Mol Biol, 2011, 410(1): 10-17.
[12] de Lange T. How telomeres solve the end-protection problem. Science, 2009, 326(5955): 948-952.
[13] Loayza D, Parsons H, Donigian J, et al. DNA binding features of human POT1. J Biol Chem, 2004, 279(13): 13241-13248.
[14] Bunch J T, Bae N S, Leonardi J, et al. Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability. Mol Cell Biol, 2005, 25(13): 5567-5578.
[15] Pitt C W, Cooper J P. Pot1 inactivation leads to rampant telomere resection and loss in one cell cycle. Nucleic Acids Res, 2010, 38(20): 6968-6975.
[16] Churikov D, Price C M. Pot1 and cell cycle progression cooperate in telomere length regulation. Nat Struct Mol Biol, 2008, 15(1): 79-84.
[17] Litman Flynn R, Chang S, Zou L. RPA and POT1: Friends or foes at telomeres? Cell Cycle, 2012,11(4): 652-657.
[18] Flynn R L, Centore R C, O’Sullivan R J, et al. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature, 2011, 471(7339): 532-536.
[19] Gong Y, de Lange T. A Shld1-controlled POT1a provides support for repression of ATR signaling at telomeres through RPA exclusion. Mol Cell. 2010, 40(3): 377-387.
[20] Rai R, Li J M, Zheng H, et al. The E3 ubiquitin ligase Rnf8 stabilizes Tpp1 to promote telomere end protection. Nat Struct Mol Biol, 2011, 18(12): 1400-1407.
[21] Sheppard S A, Loayza D. LIM-domain proteins TRIP6 and LPP associate with shelterin to mediate telomere protection. Aging (Albany NY). 2010, 2(7): 432-444.
[22] Wang F, Podell E R, Zaug A J, et al. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature, 2007, 445(7127): 506-510.
[23] Latrick C M, Cech T R. POT1-TPP1 enhances telomerase processivity by slowing primer dissociation and aiding translocation. EMBO J, 2010, 29(5): 924-933.
[24] Zaug A J, Podell E R, Nandakumar J, et al. Functional interaction between telomere protein TPP1 and telomerase. Genes Dev, 2010, 24(6): 613-622.
[25] Abreu E, Aritonovska E, Reichenbach P, et al. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol Cell Biol, 2010, 30(12): 2971-2982.
[26] Zaug A J, Podell E R, Cech T R. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc Natl Acad Sci U S A, 2005, 102(31): 10864-10869.
[27] Lei M, Zaug A J, Podell E R, et al. Switching human telomerase on and off with hPOT1 protein in vitro. J Biol Chem, 2005, 280(21): 20449-20456.
[28] Possemato R, Timmons J C, Bauerlein E L, et al. Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics. Mol Cancer Res, 2008, 6(10): 1582-1593.
[29] Gao J, Zhang J, Long Y, et al. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters. Asia Pac J Clin Oncol, 2011, 7(4): 339-345.
[30] Fujii K, Sasahira T, Moriwaka Y, et al. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer. Int J Mol Med, 2008, 21(5): 599-604.
[31] Wan S M, Tie J, Zhang Y F, et al. Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through up-regulating PinX1 expression. J Clin Pathol, 2011, 64(12): 1051-1057.
[32] Ning X, Yang S, Wang R, et al. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells. Eur J Cancer Prev, 2010, 19(5): 345-351.
[33] Xiao N, Chen S, Ma Y, et al. Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells. Biochem Biophys Res Commun. 2012, 419(3): 567-572.
[34] Kojima K, Hiyama E, Otani K, et al. Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer. Cancer Sci, 2011, 102(2): 330-335.
[35] Varadi V, Brendle A, Brandt A, et al. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer, 2009, 45(17): 3008-3016.
[36] Shen J, Gammon M D, Wu H C, et al. Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 2010, 19(1): 219-228. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
